- AdventHealth
As the health care industry continues to grapple with shortages of clinicians on a national scale, the city of Palm Coast is home to an innovative solution: a state-of-the-art facility that has become the epicenter of learning and skill refinement for clinicians across Central Florida.
Since opening in 2022, the AdventHealth Palm Coast simulation center has experienced a remarkable surge in usage. In 2023, nearly 6,000 learners benefitting from its advanced training programs, marking a 20% increase from its first year.
“In our growing communities, there’s also a growing need for more health care services and caregivers, but national workforce shortages can make it challenging to ensure there are always enough clinicians on hand to deliver high-touch patient care,” said Kevin Holt, AdventHealth Palm Coast simulation operations manager. “That’s why this simulation center is so important. It gives us new and innovative ways to train and educate our current and future workforce and support aspiring clinicians in their career journeys, all while staying close to home.”
With five meticulously designed classroom labs that replicate patient rooms, this simulation center is the largest within AdventHealth’s Central Florida network, spanning from Flagler County to Osceola County, south of Orlando.
At the core of its success lies its cutting-edge simulation technology, offering nurses a hands-on experience like no other. Through interactive manikins capable of simulating diverse health conditions and scenarios, clinicians undergo realistic training, honing their skills and preparing for the complexities of real-world health care settings.
In addition to its impact in Flagler County, the center serves as a vital training ground for clinicians from other AdventHealth facilities in the region, as well as nursing students from higher education institutions, including the University of North Florida and Jacksonville University.
Throughout 2023, the simulation center hosted nearly 200 simulation events. October was the lab’s busiest month, with 27 simulation events training more than 550 learners, underscoring the facility’s pivotal role in professional development.
“As Palm Coast and our surrounding communities continue to grow, it is more important than ever that we maintain a robust health care workforce and help shape the next generation of clinicians,” said Amy Piazza, AdventHealth director of education and onboarding. “I am so proud of the team of educators and clinicians. Through their dedication to learning, the AdventHealth Palm Coast simulation center has emerged as a beacon of excellence, elevating the local health care landscape and ensuring that present and future nurses are equipped with the skills and knowledge to serve the diverse needs of our communities.”
Recent News
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...
AdventHealth’s Karen D. Corbin, PhD, RD, Contributed to New American Diabetes Association Consensus Statement on Liver Disease in Diabetes
Metabolic dysfunction associated steatotic liver disease (MASLD), formerly referred to as nonalcoholic fatty liver disease (NAFLD), affects about 70% of people with type 2 diabetes, placing them at...
AdventHealth East Orlando First in Florida to Earn Advanced Foot & Ankle Surgery Certification from DNV
AdventHealth East Orlando recently became the first hospital in Florida to earn Advanced Foot & Ankle Surgery Certification from DNV, a worldwide, independent certification body.